Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Transforming Growth Factor, beta 3 (TGFB3) (Middle Region) Peptid

TGFB3 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN985028

Kurzübersicht für Transforming Growth Factor, beta 3 (TGFB3) (Middle Region) Peptid (ABIN985028)

Target

TGFB3 (Transforming Growth Factor, beta 3 (TGFB3))

Spezies

Human

Quelle

  • 6
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Sequenz

    EFRVLRVPNP SSKRNEQRIE LFQILRPDEH IAKQRYIGGK NLPTRGTAEW

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-TGFB3 Antibody(ARP59157_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Aufreinigung

    Purified
  • Applikationshinweise

    Each Investigator should determine their own optimal working dilution for specific applications.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Konzentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    TGFB3 (Transforming Growth Factor, beta 3 (TGFB3))

    Hintergrund

    TGFB3 is involved in embryogenesis and cell differentiation.

    Alias Symbols: ARVD, FLJ16571, TGF-beta3

    Protein Interaction Partner: TGFBR1,TGFBR2,ACVRL1,CTGF,ENG,FMOD,LTBP3,TGFB2,TGFBR1,TGFBR2,TGFBR3,VASN,TGFBR2,VASN

    Protein Size: 412

    Molekulargewicht

    47 kDa

    Gen-ID

    7043

    NCBI Accession

    NM_003239, NP_003230

    UniProt

    P10600
Sie sind hier:
Chat with us!